BPH 8.33% 1.3¢ bph energy ltd

News: Advent Energy poised to develop gas resourc, page-28

  1. 3,971 Posts.
    lightbulb Created with Sketch. 185
    Hi DManAus, David and all,

    Some investors also make decision based on business presentations and on specific statements made by directors. After all who is going to have more knowledge of a business than the man in charge of the company. If he tells share holder there is a 75% chance of success and produces a duster how do you suggest we should value his next statement?

    I don’t know how long you normally go along with statements of various company directors. Personally I become a little suspect after being told more than a few pork pies. My interpretation of something being close (August 2009) and nothing happening with MDS to date 2014 clearly differs with your own. I really don’t see that as being focused on achieving a milestone. Or to be more specific when told to look out for developments within the same financial year: Another duster!

    Somehow you think it wrong to have as you say a stab at a company director then why does this particular one supply so much ammunition. Please read the history, the following quotes / links are all in the public domain and I can supply plenty more if you wish.

    At the risk of being accused of boasting I know of some people that left school at 15 without a degree to their name making a success out of their first attempt (one company) whereas others have had 80 attempts and have yet to get a run on the board and make a payment to the ATO or heaven forbid a shareholder dividend!

    However; if you have confidence in the management and the company I wish you the very best outcome for your invested dollars.

    To be absolutely fair without ever delivering on a promise to take a share from 2.6 cents to 32.00 cents (1130%) is certainly an achievement and one up there with Bernard Madoff’s or even the original Ponzi scheme!

    By the way I feel we all have the right to make comments on these threads and if nothing else our differing views should at least highlight to all the absolute need for full and due diligence before committing any hard earned cash to any particular investment.

    As mum said always try and end on a positive note and if possible give right of reply.

    Mr David Breeze I promise to eat all my previous comments and bow down before you and apologise if you will just get my 5 M plus MDS shares from the current zero to 32 cents before either of us dies!

    Cheers and very best regards: Andy


    David has worked on the structuring, capital raising and public listing of over 80 companies involving in excess of $250M. These capital raisings covered a diverse range of areas including oil and gas, gold, biotechnology and manufacturing. David Breeze is Chairman of Grandbridge Ltd, a publicly listed investment and advisory company and BioPharmica Ltd, an ASX listed commercialisation business. He holds a Bachelor of Economics and a Masters of Business Administration (MBA) and is a Member of the Australian Institute of Management, a Senior Associate of the Financial Services Institute of Australasia and a Fellow of the Institute of Company Directors of Australia.

    http://www.zoominfo.com/p/David-Breeze/627273282

    THE WEST AUSTRALIAN Business
    thewest.com.au/business Wednesday, August 12, 2009
    BioPharmica rises after drug trials

    VIVIENNE RYAN


    BioPharmica Breeze said: “the company was focused on achieving milestones required to take
    the drug to a commercial partner.”


    August 2009

    BPH Chairman, Mr David Breeze said “We are excited about the new research being undertaken as it has excellent commercial development opportunities. Discussions have already been initiated with international companies with the objective of licensing the development of these projects. It is anticipated that the research program will enable developments in this area within this financial year”.

    BioPharmica shares have soared 1130 per cent this week, from its 2.6 cent close last Friday to 32 cents.


    http://biopharmica.com.au/documents/BPH InvOverview 2009 LR.pdf
 
watchlist Created with Sketch. Add BPH (ASX) to my watchlist
(20min delay)
Last
1.3¢
Change
0.001(8.33%)
Mkt cap ! $14.46M
Open High Low Value Volume
1.2¢ 1.3¢ 1.2¢ $616 48.08K

Buyers (Bids)

No. Vol. Price($)
29 7433777 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 924906 2
View Market Depth
Last trade - 16.10pm 26/11/2024 (20 minute delay) ?
BPH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.